Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-30

Clinical Trial Update: Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease [NA]

View source ↗

Summary

A completed clinical trial update on the safety and efficacy of TrueTear for Meibomian gland disease and related dry eye conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TrueTear

Snippet

Sponsor: Allergan | Conditions: Meibomian Glands, Dry Eye Syndromes | NA | Status: COMPLETED | Results posted: 2020-10-30